A method to separate the rectum from the prostate during proton beam radiotherapy of prostate cancer patients

References

• Pisansky TM. External-beam radiotherapy for localized prostate cancer. N Engl J Med 2006;355:1583–91.
   PubMed Web of Science ®Google Scholar
• Pollack A, Zagars GK, Starkschall G, Antolak JA, Lee JJ, Huang E, . Prostate cancer radiation dose response: Results of the M. D. Anderson phase III randomized trial. Int J Radiat Oncol Biol Phys 2002;53:1097–105.
   PubMed Web of Science ®Google Scholar
• Shipley WU, Verhey LJ, Munzenrider JE, Suit HD, Urie MM, McManus PL, . Advanced prostate cancer: The results of a randomized comparative trial of high dose irradiation boosting with conformal protons compared with conventional dose irradiation using photons alone. Int J Radiat Oncol Biol Phys 1995;32:3–12.
   PubMed Web of Science ®Google Scholar
• Zietman AL, DeSilvio ML, Slater JD, Rossi CJ Jr, Miller DW, Adams JA, . Comparison of conventional-dose vs high-dose conformal radiation therapy in clinically localized adenocarcinoma of the prostate: A randomized controlled trial. JAMA 2005;294:1233–9.
   PubMed Web of Science ®Google Scholar
• Vargas C, Yan D, Kestin LL, Krauss D, Lockman DM, Brabbins DS, . Phase II dose escalation study of image-guided adaptive radiotherapy for prostate cancer: Use of dose-volume constraints to achieve rectal isotoxicity. Int J Radiat Oncol Biol Phys 2005;63:141–9.
   PubMed Web of Science ®Google Scholar
• Vicini F, Vargas C, Edmundson G, Kestin L, Martinez A. The role of high-dose rate brachytherapy in locally advanced prostate cancer. Semin Radiat Oncol 2003;13:98–108.
   PubMed Web of Science ®Google Scholar
• Mangar SA, Huddart RA, Parker CC, Dearnaley DP, Khoo VS, Horwich A. Technological advances in radiotherapy for the treatment of localised prostate cancer. Eur J Cancer 2005;41:908–21.
   PubMed Web of Science ®Google Scholar
• Hara I, Murakami M, Kagawa K, Sugimura K, Kamidono S, Hishikawa Y, . Experience with conformal proton therapy for early prostate cancer. Am J Clin Oncol 2004;27:323–7.
   PubMed Web of Science ®Google Scholar
• Mock U, Bogner J, Georg D, Auberger T, Potter R. Comparative treatment planning on localized prostate carcinoma conformal photon-versus proton-based radiotherapy. Strahlenther Onkol 2005;181:448–55.
   PubMed Web of Science ®Google Scholar
• Benk VA, Adams JA, Shipley WU, Urie MM, McManus PL, Efird JT, . Late rectal bleeding following combined X-ray and proton high dose irradiation for patients with stages T3-T4 prostate carcinoma. Int J Radiat Oncol Biol Phys 1993;26:551–7.
   PubMed Web of Science ®Google Scholar
• Mechalakos JG, Mageras GS, Zelefsky MJ, Lyass O, van Herk M, Kooy HM, . Time trends in organ position and volume in patients receiving prostate three-dimensional conformal radiotherapy. Radiother Oncol 2002;62:261–5.
   PubMed Web of Science ®Google Scholar
• Holupka EJ, Kaplan ID, Burdette EC, Svensson GK. Ultrasound image fusion for external beam radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys 1996;35:975–84.
   PubMed Web of Science ®Google Scholar
• Astrom L, Pedersen D, Mercke C, Holmang S, Johansson KA. Long-term outcome of high dose rate brachytherapy in radiotherapy of localised prostate cancer. Radiother Oncol 2005;74:157–61.
   PubMed Web of Science ®Google Scholar
• Montelius A, Blomquist E, Naeser P, Brahme A, Carlsson J, Carlsson AC, . The narrow proton beam therapy unit at the Svedberg Laboratory in Uppsala. Acta Oncol 1991;30:739–45.
   PubMed Web of Science ®Google Scholar
• Grusell E, Montelius A, Russell KR, Blomquist E, Pellettieri L, Lilja A, . Patient positioning for fractionated precision radiation treatment of targets in the head using fiducial markers. Radiother Oncol 1994;33:68–72.
   PubMed Web of Science ®Google Scholar
• Dehnad H, Nederveen AJ, Van der Heide UA, Van Moorselaar RJA, Hofman P, Lagendijk JJW. Clinical feasibility study for the use of implanted gold seeds in the prostate as reliable positioning markers during megavoltage irradiation, Radiother Oncol 2003;67:295–302
   PubMed Web of Science ®Google Scholar
• Jung B, Montelius A, Dahlin H, Ekström P, Ahnesjö A, Högström B, . The conceptual design of a radiation oncology planning system. Comput Methods Programs Biomed 1997;52:79–92.
   PubMed Web of Science ®Google Scholar
• Montelius A, Jung B, Rikner G, Murman A, Russell K. Quality assurance tests of the TMS-radix treatment planning system. Breit A. Advanced radiation therapy tumour response monitoring and treatment planning. Berlin, Heidelberg: Springer-Verlag; 1992. 523–7.
   Google Scholar
• Russell KR, Isacsson U, Saxner M, Ahnesjö A, Montelius A, Grusell E, . Implementation of pencil kernel and depth penetration algorithms for treatment planning of proton beams. Phys Med Biol 2000;45:9–27.
   PubMed Web of Science ®Google Scholar
• Ahnesjo A, Saxner M, Trepp A. A pencil beam model for photon dose calculation. Med Phys 1992;19:263–73.
   PubMed Web of Science ®Google Scholar
• Dose formalism and models in helax-TMS. Helax AB. Uppsala, Sweden: 1998.
   Google Scholar
• Fowler JF. Fractionated radiation therapy after Strandqvist. Acta Radiol Oncol 1984;23:209–16.
   PubMed Web of Science ®Google Scholar
• Kupelian PA, Reddy CA, Klein EA, Willoughby TR. Short-course intensity-modulated radiotherapy (70 Gy at 2.5 Gy per fraction) for localized prostate cancer: Preliminary results on late toxicity and quality of life. Int J Radiat Oncol Biol Phys 2001;51:988–93.
   PubMed Web of Science ®Google Scholar
• Brenner DJ. Hypofractionation for prostate cancer radiofherapy-what are the issues? Int J Radiat Oncol Biol Phys 2003;57:912–4.
   PubMed Web of Science ®Google Scholar
• Brenner DJ, Hall EJ. Fractionation and protraction for radiotherapy of prostate carcinoma. Int J Radiat Oncol Biol Phys 1999;43:1095–101.
   PubMed Web of Science ®Google Scholar
• Brenner DJ, Martinez AA, Edmundson GK, Mitchell C, Thames HD, Armour EP. Direct evidence that prostate tumors show high sensitivity to fractionation (low alpha/beta ratio), similar to late-responding normal tissue. Int J Radiat Oncol Biol Phys 2002;52:6–13.
   PubMed Web of Science ®Google Scholar
• Fowler J, Chappell R, Ritter M. Is alpha/beta for prostate tumors really low? Int J Radiat Oncol Biol Phys 2001;50:1021–31.
   PubMed Web of Science ®Google Scholar
• Fowler JF, Ritter MA, Chappell RJ, Brenner DJ. What hypofractionated protocols should be tested for prostate cancer? Int J Radiat Oncol Biol Phys 2003;56:1093–104.
   PubMed Web of Science ®Google Scholar
• Logue JP, Cowan RA, Hendry JH. Hypofractionation for prostate cancer. Int J Radiat Oncol Biol Phys 2001;49:1522–3.
   PubMed Web of Science ®Google Scholar
• Kupelian PA, Reddy CA, Carlson TP, Willoughby TR. Dose/volume relationship of late rectal bleeding after external beam radiotherapy for localized prostate cancer: Absolute or relative rectal volume? Cancer J 2002;8:62–6.
   PubMed Web of Science ®Google Scholar
• Vargas C, Martinez A, Kestin LL, Yan D, Grills I, Brabbins DS, . Dose-volume analysis of predictors for chronic rectal toxicity after treatment of prostate cancer with adaptive image-guided radiotherapy. Int J Radiat Oncol Biol Phys 2005;62:1297–308
   PubMed Web of Science ®Google Scholar
• Ishikawa H, Tsuji H, Kamada T, Yanagi T, Mizoe JE, Kanai T, . Carbon ion radiation therapy for prostate cancer: Results of a prospective phase II study. Radiother Oncol 2006;81:57–64.
   PubMed Web of Science ®Google Scholar